Johnson George

7.1k total citations
153 papers, 4.7k citations indexed

About

Johnson George is a scholar working on Geriatrics and Gerontology, Physiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Johnson George has authored 153 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Geriatrics and Gerontology, 50 papers in Physiology and 32 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Johnson George's work include Pharmaceutical Practices and Patient Outcomes (57 papers), Smoking Behavior and Cessation (27 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (26 papers). Johnson George is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (57 papers), Smoking Behavior and Cessation (27 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (26 papers). Johnson George collaborates with scholars based in Australia, United Kingdom and Netherlands. Johnson George's co-authors include Kay Stewart, Rohan A. Elliott, David C. M. Kong, Derek Stewart, Edwin C.K. Tan, Michael Bailey, Michael J. Abramson, Amanda J. Cross, Dorothy McCaig and Katie MacLure and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Agricultural and Food Chemistry and Cochrane Database of Systematic Reviews.

In The Last Decade

Johnson George

146 papers receiving 4.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johnson George Australia 37 1.9k 1.1k 1.1k 867 774 153 4.7k
Kay Stewart Australia 35 1.4k 0.7× 789 0.7× 722 0.7× 933 1.1× 569 0.7× 128 4.0k
Christine Bond United Kingdom 43 2.5k 1.3× 2.2k 2.0× 741 0.7× 1.4k 1.7× 239 0.3× 256 6.4k
Shalom I. Benrimoj Australia 36 2.7k 1.4× 2.0k 1.8× 901 0.8× 468 0.5× 291 0.4× 184 4.8k
Terry S. Field United States 38 2.4k 1.2× 1.5k 1.4× 728 0.7× 599 0.7× 307 0.4× 101 6.4k
John R. Feussner United States 34 2.0k 1.0× 1.2k 1.1× 588 0.5× 554 0.6× 238 0.3× 72 5.0k
Walid F. Gellad United States 39 1.3k 0.6× 1.0k 0.9× 1.3k 1.2× 1.4k 1.6× 239 0.3× 246 6.2k
Björn Wettermark Sweden 41 863 0.4× 637 0.6× 615 0.6× 733 0.8× 585 0.8× 214 7.1k
Chris L. Bryson United States 35 603 0.3× 661 0.6× 1.2k 1.1× 363 0.4× 668 0.9× 64 4.3k
Marlene R. Miller United States 43 999 0.5× 952 0.9× 388 0.4× 558 0.6× 295 0.4× 124 5.3k
Flora M. Haaijer‐Ruskamp Netherlands 36 1.4k 0.7× 965 0.9× 561 0.5× 533 0.6× 246 0.3× 150 4.5k

Countries citing papers authored by Johnson George

Since Specialization
Citations

This map shows the geographic impact of Johnson George's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johnson George with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johnson George more than expected).

Fields of papers citing papers by Johnson George

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johnson George. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johnson George. The network helps show where Johnson George may publish in the future.

Co-authorship network of co-authors of Johnson George

This figure shows the co-authorship network connecting the top 25 collaborators of Johnson George. A scholar is included among the top collaborators of Johnson George based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johnson George. Johnson George is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sarwar, Muhammad Rehan, Vanessa M. McDonald, Michael J. Abramson, et al.. (2024). Credentialed pharmacist-led home medicines reviews targeting treatable traits and their impact on health outcomes in people with chronic obstructive pulmonary disease: a pre- and post-intervention study. International Journal of Clinical Pharmacy. 47(1). 157–165.
2.
Wurzel, Danielle, Brett Montgomery, Elena K. Schneider‐Futschik, et al.. (2024). Environmental impact of inhaled medicines: A Thoracic Society of Australia and New Zealand position statement. Respirology. 30(2). 101–112. 1 indexed citations
3.
Abramson, Michael J., Billie Bonevski, Ashley Webb, et al.. (2024). Varenicline and Nicotine Replacement Therapy for Smokers Admitted to Hospitals. JAMA Network Open. 7(6). e2418120–e2418120. 1 indexed citations
4.
Borg, Brigitte M., Michael J. Abramson, Eldho Paul, et al.. (2023). Different Case Finding Approaches to Optimise COPD Diagnosis: Evidence from the RADICALS Trial. International Journal of COPD. Volume 18. 1543–1554.
5.
Abramson, Michael J., et al.. (2022). Experiences of hospitalized smokers initiated on varenicline as part of a pragmatic smoking cessation trial. Journal of Addictive Diseases. 41(3). 242–250. 2 indexed citations
6.
Ilomäki, Jenni, et al.. (2022). Characterising the use of varenicline: an analysis of the Australian dispensing claims data. Addiction. 117(10). 2683–2694. 2 indexed citations
7.
Peel, Roseanne, J. Simon Bell, Amanda J. Cross, et al.. (2022). Validity of three risk prediction models for dementia or cognitive impairment in Australia. Age and Ageing. 51(12). 14 indexed citations
8.
Stewart, Kay, et al.. (2021). Pregnant women’s experiences with the management of hypertensive disorders of pregnancy: a qualitative study. BMC Health Services Research. 21(1). 1292–1292. 9 indexed citations
9.
10.
Abramson, Michael J., Grant Russell, Anne E. Holland, et al.. (2019). Interdisciplinary COPD intervention in primary care: a cluster randomised controlled trial. European Respiratory Journal. 53(4). 1801530–1801530. 30 indexed citations
11.
Izbicki, Gabriel, Grant Russell, Anne E. Holland, et al.. (2019). <p>Clinical Characteristics Of Patients With Asthma COPD Overlap (ACO) In Australian Primary Care</p>. International Journal of COPD. Volume 14. 2745–2752. 7 indexed citations
12.
13.
14.
McCrabb, Sam, Amanda Baker, John Attia, et al.. (2017). Who is More Likely to Use the Internet for Health Behavior Change? A Cross-Sectional Survey of Internet Use Among Smokers and Nonsmokers Who Are Orthopedic Trauma Patients. JMIR Mental Health. 4(2). e18–e18. 3 indexed citations
15.
Thomas, Dennis, Andrew Mackinnon, Billie Bonevski, et al.. (2016). Development and validation of a 21-item challenges to stopping smoking (CSS-21) scale. BMJ Open. 6(3). e011265–e011265. 14 indexed citations
16.
Clinical, et al.. (2013). Pharmacist-physician collaboration to optimise blood pressure control during inpatient rehabilitation. 32(6). 66. 1 indexed citations
17.
Amerena, John, et al.. (2012). Pharmacist-led lipid clinic for surgical patients with peripheral vascular disease. Figshare. 93(1107). 83–87. 4 indexed citations
18.
Stewart, Derek, Johnson George, Christine Bond, et al.. (2008). A qualitative exploration of the views of pharmacist prescribers, doctors and patients on pharmacist prescribing implementation. International Journal of Pharmacy Practice. 16. 2 indexed citations
19.
George, Johnson & Molly Thomas. (2003). 5/7 Digoxin therapy: Is there a need for change?. Indian Journal of Pharmacology. 35(2). 113–115.
20.
George, Johnson, et al.. (2001). Drug prescribing audit of ranitidine: A government hospital experience. Indian Journal of Pharmaceutical Sciences. 63(6). 491–499. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kay Stewart Breakdown of academic impact, for papers by Christine Bond Breakdown of academic impact, for papers by Shalom I. Benrimoj Breakdown of academic impact, for papers by Terry S. Field Breakdown of academic impact, for papers by John R. Feussner Breakdown of academic impact, for papers by Walid F. Gellad Breakdown of academic impact, for papers by Björn Wettermark Breakdown of academic impact, for papers by Chris L. Bryson Breakdown of academic impact, for papers by Marlene R. Miller Breakdown of academic impact, for papers by Flora M. Haaijer‐Ruskamp
Rankless by CCL
2026